Houtepen, Lotte C.
Vinkers, Christiaan H.
Carrillo-Roa, Tania
Hiemstra, Marieke
van Lier, Pol A.
Meeus, Wim
Branje, Susan
Heim, Christine M.
Nemeroff, Charles B.
Mill, Jonathan
Schalkwyk, Leonard C.
Creyghton, Menno P.
Kahn, René S.
Joëls, Marian
Binder, Elisabeth B.
Boks, Marco P. M.
Article History
Received: 13 July 2015
Accepted: 7 February 2016
First Online: 21 March 2016
Competing interests
: C.B.N.’s work has been funded by the NIH. He is a member of the scientific advisory board of the American Foundation for Suicide Prevention (AFSP), Brain & Behavior Research Foundation (BBRF), Xhale, Anxiety Disorders Association of America (ADAA), Skyland Trail, Clintara LLC and RiverMend Health LLC, and has received income sources or equity of $10,000 or more from American Psychiatric Publishing, Xhale and Clintara. He is also a member of the board of directors of the AFSP, Gratitude America and ADAA and has consulted for Xhale, Takeda, SK Pharma, Shire, Roche, Lilly, Allergan, Mitsubishi Tanabe Pharma Development America, Taisho Pharmaceutical Inc., Lundbeck, Prismic Pharmaceuticals, Clintara LLC and Total Pain Solutions (TPS). C.H.V. is an advisor for DynaCorts. M.P.M.B., T.C.-R., M.H., P.v.L., W.M., S.B., C.M.H., J.M., L.C.S., M.P.C., R.S.K., M.J., E.B.B. and L.C.H. declare no potential conflict of interest.